Vitamin D.

Active vitamin D is the signal that tells the intestine to take up calcium, turning on the transport proteins that carry it across the gut lining. Taken together, the vitamin D makes the calcium a person consumes far easier to absorb for normal bone upkeep.

The liver and kidney enzymes that convert vitamin D into its active form both rely on magnesium as a cofactor, so when magnesium runs low that activation slows. Adequate magnesium therefore supports the body's ability to use the vitamin D it already has.

Zinc ions form the finger-shaped folds in the vitamin D receptor that let it grip DNA, so the receptor depends on zinc to switch on the genes vitamin D targets. That makes zinc part of the cellular machinery vitamin D signals through.

MK-7 is the long half-life menaquinone that carboxylates the Gla proteins vitamin D upregulates, directing calcium toward bone matrix. The two are formulated together for exactly that division of labour.

Phylloquinone also serves the gamma-glutamyl carboxylase that activates the Gla proteins vitamin D induces, although it is directed more to the liver than to bone. It covers the same carboxylation step with different tissue distribution.

The vitamin D receptor and the retinoic acid receptors both heterodimerise with the retinoid X receptor, so a large retinol load can compete for the shared partner. Balanced amounts of the two fat-soluble vitamins are standard.

Cholecalciferol needs bile acids and dietary fat to enter mixed micelles, so taking it with a long-chain fat source raises the absorbed fraction. Oil-based softgels follow the same logic.

Medium-chain triglycerides are a common carrier for cholecalciferol drops because they solubilise it and are readily emulsified. Long-chain fats form micelles somewhat more effectively, so the vehicle choice affects uptake.

Cod liver oil supplies vitamin D and preformed retinol in one lipid matrix, so it contributes to the vitamin D total while also adding a retinol load. Both amounts need counting together with any separate doses.

Strontium is absorbed by the same vitamin D-dependent calcium transport machinery and competes with calcium for it, so taking the two together lowers uptake of each. Standard practice separates strontium from calcium and vitamin D doses.

The cytochrome P450 hydroxylases that convert cholecalciferol to 25-hydroxyvitamin D and then to the active metabolite depend on FAD-containing reductases for their electrons. Riboflavin status sits behind that electron supply.

Calcitriol increases intestinal absorption of phosphate as well as calcium, and bone mineral is laid down as calcium phosphate, so both minerals have to be present for mineralisation to proceed. Phosphate handling is also under parathyroid hormone and FGF23 control, which vitamin D status feeds into. The relationship is regulatory physiology rather than a tested supplement pairing.

Small human studies have reported that boron intake changes circulating 25-hydroxyvitamin D and steroid metabolite concentrations, with a proposed effect on hydroxylase activity or metabolite clearance. The evidence base is small and measured in blood markers, and a marker is not an outcome. Formulators pair the two for this reason and the mechanism is not settled.

Cholecalciferol is lipophilic and its absorption depends on incorporation into mixed micelles, which requires dietary fat and bile. A concentrated fish oil provides both the fat load and a compatible carrier in a single softgel. The pairing is delivery chemistry, not a claim about a combined effect.

Krill oil carries its fatty acids largely as phospholipids, which are themselves surface-active and take part in micelle formation. That gives a fat-soluble vitamin dissolved in it a compatible delivery matrix. The trade-off is that krill oil is dosed at lower fatty acid concentration than a refined fish oil, so the fat load per capsule is smaller.

Bile salts are what emulsify dietary fat into micelles, and without them fat-soluble vitamin absorption falls sharply. People with reduced bile output, including after gallbladder removal, are the group in whom this dependency shows up most clearly. Supplemental bile acids are used in that setting as a digestive aid rather than as a vitamin D enhancer with trial support.

Triglycerides have to be hydrolysed by pancreatic lipase before their products can assemble into the mixed micelles that carry cholecalciferol across the enterocyte membrane. Where lipase output is low, fat-soluble vitamin absorption drops alongside fat absorption. This is digestive physiology and applies to all four fat-soluble vitamins equally.

Lecithin phospholipids lower interfacial tension and help disperse an oil-soluble vitamin into an aqueous phase, which is why they appear in liposomal and emulsified vitamin D products. The formulation rationale is dispersion, and head-to-head absorption data across delivery systems is limited. This is formulation practice.

Phosphatidylcholine is the principal phospholipid in both bile and in liposomal delivery systems, and it participates directly in the mixed micelles that transport cholecalciferol. Formulations pair the two to build a dispersed rather than a plain oil matrix. The basis is delivery chemistry, not an outcome comparison.

Calcitriol induces the intestinal calcium transport machinery, including the apical channel and the calcium-binding protein that ferries calcium across the enterocyte, so active calcium absorption is vitamin D dependent. Calcium carbonate additionally needs stomach acid to dissolve, so it is taken with food. The pair is the standard bone-support combination for that reason.

Tocopherols and cholecalciferol are both taken up from the same mixed micelles and use overlapping intestinal transport proteins, so a very large dose of one can reduce the fractional uptake of the other from the same meal. The effect is meaningful at high supplemental doses rather than at nutritional intakes. It is a reason to watch total fat-soluble vitamin load in a stack.

Carotenoids compete for space in mixed micelles and for the same scavenger receptor-mediated uptake step used by other lipid-soluble micronutrients. High single doses of a carotenoid taken in the same meal can lower the absorbed fraction of a co-dosed fat-soluble vitamin. Spacing the doses or splitting them across meals is the usual formulation answer.